Last updated 2026-07-26
- Raised $1M Seed round, Aug 2019
- Raised $950k Pre-Seed round, Sep 2017
Total raised
$1.9M
Last: Undisclosed Round 2019-09
Stage
Seed
Founded
2014
Headcount
2
HQ
Herzliya, Israel
Sector
Health Tech & Life Sciences
About
Bioimmunate Technologies is developing a breakthrough therapeutic filter to treat autoimmune diseases, specifically Multiple Sclerosis. The company's device utilizes precise medicine technology for blood filtration, removing harmful cells from the human body to provide safer therapies without side effects. Each procedure uses two disposable filters per patient, with two to three procedures annually, aiming to replace traditional MS drug treatments.
Funding history · 2 rounds · $1.9M total
2019-08
Seed
$1.0M
2017-09
Pre-Seed
$950K
Q&A
- What is Bioimmunate Technologies' primary focus?
- Bioimmunate Technologies is developing a personalized medical platform designed to treat autoimmune diseases, specifically Multiple Sclerosis, through blood filtration.
- When was Bioimmunate Technologies founded?
- Bioimmunate Technologies was founded in 2014.
- What is the total amount of funding Bioimmunate Technologies has raised to date?
- Bioimmunate Technologies has raised a total of $2,950,000 in funding.
- What is the current employee count for Bioimmunate Technologies?
- Bioimmunate Technologies has 1-10 employees.
- Who are the co-founders of Bioimmunate Technologies?
- The co-founders of Bioimmunate Technologies are Sigalit Carmel and Eitan Yanov.
- What is Bioimmunate Technologies' primary sector?
- Bioimmunate Technologies' primary sector is Health Tech & Life Sciences.
- What is the core technology developed by Bioimmunate Technologies?
- Bioimmunate Technologies has developed unique biological filters anchored inside special particles that recognize, capture, and remove harmful cells from a patient's blood before they reach the central nervous system, aiming to treat autoimmune diseases like Multiple Sclerosis.
Team · 2
Sigalit Carmel
Founder · CEO & Co-Founder
Eitan Yanov
Founder · Co-Founder
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
BiologicalsCells
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B2C
Highlights
1 PatentsVerified
Tags
multiple-sclerosismedical-technologiesmedical-deviceshospitalspatientsautoimmune-diseasesbioconvergence
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | expireddomains.com/domain/bioimmunate.com |
|---|
Identifiers & details
| Legal name | Bioimmunate Technologies Ltd. |
|---|---|
| Founded | 2014 |
| Employees (exact) | 2 |
Radar intelligence
Patents
| EPO | 1 |
|---|
Web history (Wayback)
| Domain | expireddomains.com |
|---|
Certificate / subdomain footprint
| Subdomains | 10 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 515101384 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2014-07-03 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | yes |
| Last annual report | 2023 |
| Active charges / liens | 0 |
| Registry events | 3 — violation (1), people (2) |
| Registered address | השפלה 3 רמת השרון |
Recent registry events
| Date | Event |
|---|---|
| 2026-06-25 | עדכון הפרה |
| 2025-09-09 | עדכון דירקטורים-הסרת דירקטור |
| 2025-09-07 | עדכון בעלי תפקידים |